Q20H (p.Gln20His) variant of PAH (Phenylalanine-4-hydroxylase)

Q20H (p.Gln20His) in PAH (Phenylalanine-4-hydroxylase) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance in the context of in PAH deficiency. The available variant effect predictions contribute to a CATVariant prioritization score of 0.63 / 1. The record also includes published literature and structural context.

Q20H (p.Gln20His) variant details